HCPLive Network

Neuropathic Pain

Noting the management and treatment of postherpetic neuralgia (PHN) are currently subpar in the primary care setting, 2 researchers recently reviewed and outlined key clinical considerations for the chronic neuropathic pain syndrome.
Patients who also responded positively to preoperative non-invasive transcranial stimulation analgesic effect were more likely to experience long-term benefit from MCS.
The newly approved naloxone auto-injector has the potential to save many lives, but should not be viewed as the Holy Grail of the ongoing fight to prevent overdose deaths from opioid abuse and misuse.
For patients suffering from hip bursitis, platelet-rich plasma treatment is more effective than steroids, according to a study presented at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons.
Scientists are able to predict the body's response to neuropathic pain treatment, according to a study presented at the 30th Annual Meeting of the American Academy of Pain Medicine.
While the peak of the opioid epidemic may now have been reached (according to some), we are not out of the woods. Every decision to start or continue opioid therapy must be careful, deliberate, and weigh benefit against risk, while keeping in mind that risk is not constant/static, but dynamic and evolves through time.